| II-58 Ida Neldemo The tumor time-course predicts the overall survival in non-small cell lung cancer patients treated with atezolizumab in a large Phase I study: an evaluation of using different censoring times Wednesday 15:10-16:40 |
| II-58 Ida Neldemo The tumor time-course predicts the overall survival in non-small cell lung cancer patients treated with atezolizumab in a large Phase I study: an evaluation of using different censoring times Wednesday 15:10-16:40 |